And over the last few years, MEAI is one of the most exciting drugs out there. MEAI, which is a 5-methoxy – 2-aminoindane compound, is a non-hallucinogenic, synthetic psychedelic’ has been shown to possess the potential of becoming an incredible therapeutic drug for hard-to-treat conditions including alcoholism. It was created by the Chief Scientific Officer of Clearmind Medicine, a biotech firm focused on developing psychedelic-based drugs that are aimed at solving common health issues such as alcohol use disorder, addiction, and obesity. However, their flagship treatment is focused on alcohol use disorder since it’s so common, as well as obesity.
Legal on paper, restricted in practice. Inside Germany’s cannabis system, where cultivation is allowed but…
The idea may sound strange: a tobacco plant producing compounds like psilocybin or DMT. Sounds…
The term “addiction” gets thrown around quite freely in everyday language—this is nothing new. Who…
Three days before the Trump administration moved medical marijuana to Schedule III, a new YouGov…
On April 23, 2026, the Trump administration officially moved FDA-approved marijuana products and marijuana products…
Here we are in 2026, and a conflict that was supposed to wrap up in…